Literature DB >> 23684984

Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4.

Kyoko Ochiai1, Mark Maienschein-Cline, Giorgia Simonetti, Jianjun Chen, Rebecca Rosenthal, Robert Brink, Anita S Chong, Ulf Klein, Aaron R Dinner, Harinder Singh, Roger Sciammas.   

Abstract

The transcription factor IRF4 regulates immunoglobulin class switch recombination and plasma cell differentiation. Its differing concentrations appear to regulate mutually antagonistic programs of B and plasma cell gene expression. We show IRF4 to be also required for generation of germinal center (GC) B cells. Its transient expression in vivo induced the expression of key GC genes including Bcl6 and Aicda. In contrast, sustained and higher concentrations of IRF4 promoted the generation of plasma cells while antagonizing the GC fate. IRF4 cobound with the transcription factors PU.1 or BATF to Ets or AP-1 composite motifs, associated with genes involved in B cell activation and the GC response. At higher concentrations, IRF4 binding shifted to interferon sequence response motifs; these enriched for genes involved in plasma cell differentiation. Our results support a model of "kinetic control" in which signaling-induced dynamics of IRF4 in activated B cells control their cell-fate outcomes.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23684984      PMCID: PMC3690549          DOI: 10.1016/j.immuni.2013.04.009

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  29 in total

1.  PU.1 exhibits partial functional redundancy with Spi-B, but not with Ets-1 or Elf-1.

Authors:  L A Garrett-Sinha; R Dahl; S Rao; K P Barton; M C Simon
Journal:  Blood       Date:  2001-05-01       Impact factor: 22.113

2.  Regulation of B lymphocyte and macrophage development by graded expression of PU.1.

Authors:  R P DeKoter; H Singh
Journal:  Science       Date:  2000-05-26       Impact factor: 47.728

3.  Alternate pathways for Bcl6-mediated regulation of B cell to plasma cell differentiation.

Authors:  Jukka Alinikula; Kalle-Pekka Nera; Sini Junttila; Olli Lassila
Journal:  Eur J Immunol       Date:  2011-07-06       Impact factor: 5.532

Review 4.  The genetic network controlling plasma cell differentiation.

Authors:  Stephen L Nutt; Nadine Taubenheim; Jhagvaral Hasbold; Lynn M Corcoran; Philip D Hodgkin
Journal:  Semin Immunol       Date:  2011-09-15       Impact factor: 11.130

5.  IFN regulatory factor 8 restricts the size of the marginal zone and follicular B cell pools.

Authors:  Jianxun Feng; Hongsheng Wang; Dong-Mi Shin; Marek Masiuk; Chen-Feng Qi; Herbert C Morse
Journal:  J Immunol       Date:  2010-12-22       Impact factor: 5.422

6.  Discovering transcription factor regulatory targets using gene expression and binding data.

Authors:  Mark Maienschein-Cline; Jie Zhou; Kevin P White; Roger Sciammas; Aaron R Dinner
Journal:  Bioinformatics       Date:  2011-11-13       Impact factor: 6.937

7.  Transcription factor IRF4 determines germinal center formation through follicular T-helper cell differentiation.

Authors:  Nadine Bollig; Anne Brüstle; Kerstin Kellner; Waltraud Ackermann; Elfadil Abass; Hartmann Raifer; Bärbel Camara; Cornelia Brendel; Gavin Giel; Evita Bothur; Magdalena Huber; Christoph Paul; Alexandra Elli; Richard A Kroczek; Roza Nurieva; Chen Dong; Ralf Jacob; Tak W Mak; Michael Lohoff
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-02       Impact factor: 11.205

8.  Bach2 represses plasma cell gene regulatory network in B cells to promote antibody class switch.

Authors:  Akihiko Muto; Kyoko Ochiai; Yoshitaka Kimura; Ari Itoh-Nakadai; Kathryn L Calame; Dai Ikebe; Satoshi Tashiro; Kazuhiko Igarashi
Journal:  EMBO J       Date:  2010-10-15       Impact factor: 11.598

9.  A genomic regulatory element that directs assembly and function of immune-specific AP-1-IRF complexes.

Authors:  Elke Glasmacher; Smita Agrawal; Abraham B Chang; Theresa L Murphy; Wenwen Zeng; Bryan Vander Lugt; Aly A Khan; Maria Ciofani; Chauncey J Spooner; Sascha Rutz; Jason Hackney; Roza Nurieva; Carlos R Escalante; Wenjun Ouyang; Dan R Littman; Kenneth M Murphy; Harinder Singh
Journal:  Science       Date:  2012-09-13       Impact factor: 47.728

10.  An incoherent regulatory network architecture that orchestrates B cell diversification in response to antigen signaling.

Authors:  Roger Sciammas; Ying Li; Aryeh Warmflash; Yiqiang Song; Aaron R Dinner; Harinder Singh
Journal:  Mol Syst Biol       Date:  2011-05-24       Impact factor: 11.429

View more
  161 in total

1.  Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses.

Authors:  Clayton A White; Egest J Pone; Tonika Lam; Connie Tat; Ken L Hayama; Guideng Li; Hong Zan; Paolo Casali
Journal:  J Immunol       Date:  2014-11-12       Impact factor: 5.422

2.  Structural Studies of IRF4 Reveal a Flexible Autoinhibitory Region and a Compact Linker Domain.

Authors:  Soumya G Remesh; Vishaka Santosh; Carlos R Escalante
Journal:  J Biol Chem       Date:  2015-09-24       Impact factor: 5.157

3.  Regulation of bifurcating B cell trajectories by mutual antagonism between transcription factors IRF4 and IRF8.

Authors:  Heping Xu; Virendra K Chaudhri; Zhiguo Wu; Konstantinos Biliouris; Krista Dienger-Stambaugh; Yrina Rochman; Harinder Singh
Journal:  Nat Immunol       Date:  2015-10-05       Impact factor: 25.606

Review 4.  B Cells, Antibodies, and More.

Authors:  William Hoffman; Fadi G Lakkis; Geetha Chalasani
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-23       Impact factor: 8.237

5.  Haploinsufficiency of interferon regulatory factor 4 strongly protects against autoimmune diabetes in NOD mice.

Authors:  Satoru Akazawa; Masakazu Kobayashi; Genpei Kuriya; Ichiro Horie; Liping Yu; Hironori Yamasaki; Minoru Okita; Yuji Nagayama; Toshifumi Matsuyama; Masoud Akbari; Katsuyuki Yui; Atsushi Kawakami; Norio Abiru
Journal:  Diabetologia       Date:  2015-08-14       Impact factor: 10.122

6.  The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma.

Authors:  Rebecca L Boddicker; N Sertac Kip; Xiaoming Xing; Yu Zeng; Zhi-Zhang Yang; Jeong-Heon Lee; Luciana L Almada; Sherine F Elsawa; Ryan A Knudson; Mark E Law; Rhett P Ketterling; Julie M Cunningham; Yanhong Wu; Matthew J Maurer; Megan M O'Byrne; James R Cerhan; Susan L Slager; Brian K Link; Julie C Porcher; Deanna M Grote; Diane F Jelinek; Ahmet Dogan; Stephen M Ansell; Martin E Fernandez-Zapico; Andrew L Feldman
Journal:  Blood       Date:  2015-04-01       Impact factor: 22.113

7.  The NF-κB genomic landscape in lymphoblastoid B cells.

Authors:  Bo Zhao; Luis A Barrera; Ina Ersing; Bradford Willox; Stefanie C S Schmidt; Hannah Greenfeld; Hufeng Zhou; Sarah B Mollo; Tommy T Shi; Kaoru Takasaki; Sizun Jiang; Ellen Cahir-McFarland; Manolis Kellis; Martha L Bulyk; Elliott Kieff; Benjamin E Gewurz
Journal:  Cell Rep       Date:  2014-08-21       Impact factor: 9.423

8.  Preconditioned mesenchymal stem cells treat myasthenia gravis in a humanized preclinical model.

Authors:  Muriel Sudres; Marie Maurer; Marieke Robinet; Jacky Bismuth; Frédérique Truffault; Diane Girard; Nadine Dragin; Mohamed Attia; Elie Fadel; Nicola Santelmo; Camille Sicsic; Talma Brenner; Sonia Berrih-Aknin
Journal:  JCI Insight       Date:  2017-04-06

9.  IRF4 modulates the response to BCR activation in chronic lymphocytic leukemia regulating IKAROS and SYK.

Authors:  Rossana Maffei; Stefania Fiorcari; Stefania Benatti; Claudio Giacinto Atene; Silvia Martinelli; Patrizia Zucchini; Leonardo Potenza; Mario Luppi; Roberto Marasca
Journal:  Leukemia       Date:  2021-02-23       Impact factor: 11.528

10.  The forkhead transcription factor FOXP1 represses human plasma cell differentiation.

Authors:  Martine van Keimpema; Leonie J Grüneberg; Michal Mokry; Ruben van Boxtel; Menno C van Zelm; Paul Coffer; Steven T Pals; Marcel Spaargaren
Journal:  Blood       Date:  2015-08-19       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.